Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and ...

Quoted Finnish pharmaceutical company Orion Corporation is establishing a new research & development centre in Cambridge to ...

Immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics, discusses the promise of harnessing natural killer cells to reshape treatment for cancer and autoimmune disease.

Key Innovations and 5 Companies to Watch in 2025Artificial intelligence is everywhere in 2024, changing industries and ...

Sanofi has made an interesting choice for its ... medicines from discovery to market," alluding to a long career in biopharma that has included founding roles in Alchemab Therapeutics, Dualitas ...

The statement by the Minister of Industry, Trade and Investment, Jumoke Oduwole that 30 foreign trips undertaken by President Bola Tinubu have attracted proposed investments worth $50.8 billion into ...

Versatope Therapeutics Incorporated, a biotechnology company developing vaccines and immuno-therapeutics announced today Edward Jordan and Sam Rasty have joined the company's Board of Directors and ...

The conference theme this year focused on collaboration, connection, and cultivation of the next generation of researchers.

NFL star and Jacksonville Jaguars linebacker Chad Muma was diagnosed with Type 1 Diabetes at 13 years old, but that has never ...

Sanofi stock is surging with a Golden Cross formation and promising Dupixent results. With FDA review and potential approval, investors are excited.

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

Positive results from the pivotal ADEPT phase 2/3 study evaluating the investigational use of Dupixent (dupilumab) in adults with moderate-to-severe bullous pemphigoid (BP) were shared in a ...